Clinical trial
Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That…
NCT00030108 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00030108 |
|---|---|
| Title | Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy |
| Official title | Phase I Trial and Pharmacokinetic Study of BMS-247550 (NSC 710428, Ixabepilone), an Epothilone B Analog, in Pediatric Patients With Refractory Solid Tumors and Leukemias |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Kidney Cancer, Leukemia, Liver Cancer, Neuroblastoma, Ovarian Cancer, Sarcoma, Unspecified Childhood Solid Tumor and 1 more |
| Intervention type | Drug |
| Interventions | ixabepilone |
| Enrollment | 30 |
| Start date | Nov 1, 2001 |
| Primary completion | Mar 1, 2010 |
| Completion | Apr 1, 2010 |
| First posted | Jan 27, 2003 |
| Last update posted | Mar 15, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: